Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT05188612
Recruiting Observational

International Survey of Acute Coronavirus Syndromes-COVID-19

NCT05188612 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Bologna
Phase
Observational
Started
2021-12-01
Last updated
2026-05-01

Condition(s) studied

COVID-19

Investigational drug(s) / intervention(s)

Observational (registry)

Observational (registry): Observational (Patient Registry)

Study summary

In response to the COVID-19 crisis, ISACS-TC has promoted a new registry of the existing and further centers of the same geographic areas to support clinical research to prevent, and treat the COVID-19 illness. These efforts are made possible by the generous contributions of clinical research volunteers in some of the countries participating to the prior acute coronary syndrome network.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years (male or female) * Patients admitted to any hospital center with a confirmed diagnosis of COVID-19 infection. Exclusion Criteria: • Underage or not able to give informed consent

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
University of Bologna Bologna Bologna Recruiting
IR-Hospital de la Santa Creu i Sant Pau, UAB Barcelona Spain Recruiting

More University of Bologna trials in Italy

Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox Starting soon
Robotic vs Open Nephrectomy for ADPKD Active, not recruiting
The International Survey of Acute Coronary Syndromes-ARCHIVES Enrolling by invitation
Success and Survival Rate of Tranmucosal Versus Bone Level Implants: Randomized Clinical Trial Active, not recruiting
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy Active, not recruiting

Other trials for the same condition

Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project Recruiting
Post COVID-19 Condition Recruiting
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial Recruiting
Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW) Recruiting
Randomized Controlled Trial of the Mindful Compassion Care Program in Reducing Psychological Distress Amongst Nurses During the COVID-19 Pandemic Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05188612 on ClinicalTrials.gov ↗ ← All trials in Italy